B

Boston Scientific Corp

BSXNYSEHEALTHCARE
$46.61+0.00 (+0.00%)
Market closedPrev close $46.61

AlphaYou read

Insider Cluster

LONGLive
16/ 100
WeakScore 16 / 100Saved Jun 10, 2026

Smart-money signal on BSX this 14d.

Looks good

Smart-money signal on BSX this 14d.

Watch risk

Pending dilution: 1 S-3/S-8 shelf in trailing 90d

Changed

Saved Jun 10, 2026. Day 2 of 30D; +0.0% vs S&P so far.

  • Smart money4.0/40
  • Fundamentals6.5/35
  • Technicals3.8/15
  • Macro2.0/10

Price

Stock chart

3calls marked
Prior call3

Snapshot

Quick facts

Updated Jun 11
Market cap
$72.77B
P/E ratio
20.49
Forward P/E
14.58
Beta
0.56
52-week range
$47.17 - $109.50
Dividend yield
--
Volume
2.75M
Sector
HEALTHCARE

Analysts

What do analysts expect?

Live

Current

$46.61

Target

$78.17

+31.56 (+67.7%) possible upside12 months

Saved calls

Recent AlphaYou calls for this stock

  • LONGJun 10
    Insider Cluster

    Smart-money signal on BSX this 14d.

    Public call·Results pending
  • LONGMay 29
    Insider Cluster

    Smart-money signal on BSX this 14d.

    Public call·Results pending
  • LONGMay 22
    Insider Cluster

    3 insiders bought $554K of BSX this 14d.

    Public call·Results pending

Smart money

What big buyers and insiders are doing

Live26 items
  • congressional trade

    Rep. Hon. Gilbert Cisneros bought BSX ($1,001-$15,000)

    +1.0
  • congressional trade

    Rep. Hon. Gilbert Cisneros bought BSX ($1,001-$15,000)

    +1.0
  • congressional trade

    Rep. Hon. Gilbert Cisneros bought BSX ($1,001-$15,000)

    +1.0
  • filing 13f fund flow

    Renaissance Technologies LLC holds $227.2M (13F 2025-12-31)

    +5.0
  • filing 13f fund flow

    Two Sigma Investments LP holds $590.6M (13F 2026-03-31)

    +4.0
  • filing 13f fund flow

    Citadel Advisors LLC holds $455.4M (13F 2025-12-31)

    +4.0

Top trader activity

Pending

Real trader activity will show here once the feed is ready.

BTC Astro risk regime

Pending

A broad risk read. Used only as context, not as the main stock reason.

Who helped?

Sources tied to past calls on this stock

Source types

  • SEC EDGAR Form 4

    Source family

    D7

    178

    +2.08%

    61.8% hit

    D15

    118

    +2.76%

    65.3% hit

    D30

    8

    +3.02%

    62.5% hit

  • SEC EDGAR 13F

    Source family

    D7

    173

    +1.16%

    59.5% hit

    D15

    116

    +0.68%

    53.4% hit

    D30

    pending

  • SEC EDGAR NPORT-P

    Source family

    D7

    40

    +2.61%

    62.5% hit

    D15

    4

    +3.53%

    50.0% hit

    D30

    1

    -10.02%

    0.0% hit

  • house-clerk-ptr-pdf

    Source family

    D7

    26

    +0.93%

    53.8% hit

    D15

    16

    +4.01%

    75.0% hit

    D30

    2

    -7.82%

    0.0% hit

Funds, insiders, and filers

Did it work?

How past calls did

Soon

No results yet for this stock.

Results appear 7, 15, and 30 days after a call.

Each row shows what happened after the call. Green means it beat the comparison; red means it lagged.

Source links

Can you check the original source?

LiveRules
100.0%
Linked
9
Items
3
Calls
3
Public calls
Source links9/9
house-clerk-ptr-pdf3/3 linked
SEC EDGAR Form 43/3 linked
SEC EDGAR NPORT-P2/2 linked
SEC EDGAR 13F1/1 linked
Recent source items
  • house-clerk-ptr-pdf

    CONGRESSIONAL TRADE · Jun 8· source

    linked
  • house-clerk-ptr-pdf

    CONGRESSIONAL TRADE · Jun 8· source

    linked
  • house-clerk-ptr-pdf

    CONGRESSIONAL TRADE · Jun 8· source

    linked
  • SEC EDGAR NPORT-P

    FILING NPORT P FUND FLOW · May 29· source

    linked
  • SEC EDGAR NPORT-P

    FILING NPORT P FUND FLOW · May 29· source

    linked
  • SEC EDGAR Form 4

    INSIDER BUY · May 21· source

    linked
  • SEC EDGAR Form 4

    INSIDER BUY · May 21· source

    linked
  • SEC EDGAR Form 4

    INSIDER BUY · May 21· source

    linked

Fundamentals

Is the business strong?

Live

Valuation

  • P/E20.49
  • Forward P/E14.58
  • P/S3.53
  • P/B2.81

Quality

  • Profit margin17.3%
  • Operating margin20.6%
  • ROE14.7%
  • ROA6.1%

Growth

  • Revenue YoY--
  • Earnings YoY--
  • Beta0.56
  • Dividend yield--

Technicals

Chart health

Live

Trailing returns

  • 5d+0.43%
  • 20d-0.13%
  • 60d+0.13%

Trend vs moving averages

  • vs SMA50+0.57%
  • vs SMA200-0.56%

52w range position

$47.170%$109.50

Based on daily price data. Options flow and order-book data are not in this chart panel yet.

Macro

Market backdrop

Live
  • sector rotation

    5/11 sectors leading SPY by >=1pp over 20d (broad-based uptrend)

    +1.0
  • macro regime shift

    Speculator (leveraged-money) net short on E-MINI S&P 500 at 1.9th percentile vs trailing 52w (extreme bearish positioning, mean-reversion bullish) as of 2026-06-02

    +1.0
  • macro regime shift

    VIX 15.7 (low volatility) as of 2026-05-28

    +15.7
  • macro regime shift

    10y-2y spread 46bps (flattish) as of 2026-05-28

    +0.5
  • macro regime shift

    Industrial Production 102.5 (mild expansion) as of 2026-04-01

    +102.5

Earnings

Did earnings help or hurt?

Live
$0.83$0.76$0.69$0.62$0.55Q2 '24Q4 '24Q2 '25Q4 '25Q1 '26
BeatMissMatchEstimate

Bull vs bear

What could help or hurt?

Live
  • Bullish view

    • Rep. Hon. Gilbert Cisneros bought BSX ($1,001-$15,000)
    • Rep. Hon. Gilbert Cisneros bought BSX ($1,001-$15,000)
    • Rep. Hon. Gilbert Cisneros bought BSX ($1,001-$15,000)
    • Renaissance Technologies LLC holds $227.2M (13F 2025-12-31)

    Bearish view

    • Pending dilution: 1 S-3/S-8 shelf in trailing 90d
    • Pending dilution: 1 S-3/S-8 shelf in trailing 90d
    • Pending dilution: 1 S-3/S-8 shelf in trailing 90d

Reasons come from smart money, fundamentals, technicals, and macro. Counts show how many reasons sit on each side.

Scorecard

Past call results

vs SPY

S&P 500

2 calls · 2L · 0S

Typical edge

-6.98%

Avg edge

-6.98%

Hit rate

50.0%

Mean return

-7.50%

vs QQQ

Nasdaq-100

2 calls · 2L · 0S

Typical edge

-6.70%

Avg edge

-6.70%

Hit rate

50.0%

Mean return

-7.50%

Results are grouped by stock, direction, and day so the same call is not counted twice.